Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort Study

BACKGROUND AND AIMS: Corticosteroid-free remission is a primary treatment goal in IBD which may be achieved with greater use of anti-TNF therapy. We defined temporal trends of corticosteroid use, anti-TNF use, hospitalization and surgery in a prevalent IBD cohort within the province of Alberta, Cana...

Descripción completa

Detalles Bibliográficos
Autores principales: Seow, Cynthia H, Coward, Stephanie, Kroeker, Karen I, Stach, Jesse, Devitt, Katharine Sarah, Targownik, Laura E, Nguyen, Geoffrey C, Ma, Christopher, deBruyn, Jennifer C, Carroll, Matthew W, Peerani, Farhad, Baumgart, Daniel C, Ryan, David J, Veldhuyzen van Zanten, Sander, Benchimol, Eric I, Kaplan, Gilaad G, Panaccione, Remo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713636/
https://www.ncbi.nlm.nih.gov/pubmed/36467595
http://dx.doi.org/10.1093/jcag/gwac021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713636/
https://www.ncbi.nlm.nih.gov/pubmed/36467595
http://dx.doi.org/10.1093/jcag/gwac021

Ejemplares similares